---
state_version: 1
status: DISCOVERY
current_phase: 0
current_milestone: NONE
active_task_id: NONE
last_completed_task_id: NONE
build_status: NOT_RUN
updated: 2026-09-17
---

# Project State

This is the compact current truth about project progress. Update it after every material work session.

## Current outcome

The project is in discovery. Group 0 is complete. Core loop, persistent procedural seeds, representative prototype floor, 500-HP stationary source spawning every 8 seconds, clear-after-source rule, 10/100 enemy limits, combat, mutation systems, and the approved prototype are recorded.

## Current phase

Phase 0 — Discovery and specification.

## Current milestone

No implementation milestone exists yet.

## Active task

None. Discovery questions are the current work.

## Last completed work

- Repository workflow and architecture templates created.
- Discovery Group 0 completed and working agreement accepted.

## Build and validation

| Check | Last result | Date | Notes |
|---|---|---|---|
| Game specification structure | NOT_RUN | 2026-09-17 | Run `python tools/validate_game_spec.py`. |
| Workflow state | NOT_RUN | 2026-09-17 | Run `python tools/validate_workflow_state.py`. |
| Architecture | NOT_RUN | 2026-09-17 | Run `python tools/validate_architecture.py`. |
| Godot headless import | NOT_RUN | 2026-09-17 | Requires Godot 4.x. |
| Tests | NOT_RUN | 2026-09-17 | No gameplay tests yet. |

## Known blockers

- `GAME_SPEC.md` contains unanswered discovery fields.
- The 48-hour prototype scope is approved; delivery risk remains high for one developer.
- Mutation numeric thresholds and repeat-loss trigger, enemy navigation, weapon numbers, technical budgets, and shop balance are not yet defined.

## Current risks

- The concept, main risk/reward loop, and 48-hour vertical-prototype scope are approved; full MVP content scope remains open.
- Browser delivery with hybrid 2D characters in 3D levels requires an early performance and readability prototype.
- Destructible environments may create significant production and performance cost.

## Next action

Define mutation-meter numbers, ability thresholds, antidote amount, control-ampule effect, and repeat-loss trigger.

## Handoff notes

The representative prototype floor and exact initial infection-source rules are recorded. No implementation is in progress.
